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Dose-guided radiotherapya b s t r a c t
Purpose: To evaluate whether adaptive radiotherapy for unaccounted stomach changes in patients with
adenocarcinoma of the gastroesophageal junction (GEJ) is necessary and whether dose differences could
be prevented by giving patients food and fluid instructions before treatment simulation and radiotherapy.
Material and methods: Twenty patients were randomly assigned into two groups: patients with and with-
out instructions about restricting food and fluid intake prior to radiotherapy simulation and treatment.
Redelineation and offline recalculation of dose distributions based on cone-beam computed tomography
(n = 100) were performed. Dose–volume parameters were analysed for the clinical target volume extend-
ing into the stomach.
Results: Four patients who did not receive instructions had a geometricmiss (0.7–12 cm3) in only one frac-
tion.With instructions, 3 out of 10 patients had a geometric miss (0.1–1.9 cm3) in one (n = 2) or two (n = 1)
fractions. The V95% was reduced by more than 5% for one patient, but this underdosage was in an in-air
region without further clinical importance.
Conclusions: Giving patients food and fluid instructions for the treatment of GEJ cancer offers no clinical
benefit. Using a planning target volumemargin of 1 cm implies that there is no need for adaptive radiother-
apy for GEJ tumours.
 2015 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 117 (2015) 442–447A high level of evidence currently suggests that neoadjuvant
chemoradiation (CRT) followed by surgery is the most efficient
combination for improving survival in patients with oesophageal
cancer [1]. In the Western world, a rise in the incidence of adeno-
carcinoma is observed, mostly located in the distal oesophagus or
at the gastroesophageal junction (GEJ). The oesophagus is drained
by a dense plexus of lymphatics, and disease readily spreads
microscopically along this plexus, both superiorly and inferiorly
from the primary tumour. Because of this behaviour, it is standard
treatment planning practice to apply generous margins
(30–50 mm) in the direction of mucosal tumour spread when
defining the clinical target volume (CTV) [2]. The importance of
this margin was recently shown in a study by Muijs et al. [3] that
found that any microscopic remnant outside the radiotherapy fieldhas a high impact on overall survival and disease free survival. For
GEJ tumours, the CTV will inevitably extend into the stomach.
Over the course of radiotherapy, the dose delivery will be influ-
enced by a number of factors: e.g. patient setup, anatomical
changes and respiratory motion. The latter can be better controlled
by implementing four-dimensional computed tomography (4D CT)
for treatment simulation. Furthermore, several studies [4–6] have
reported that dosimetric errors introduced by respiratory motion
tend to average out with fractionation. Unfortunately, even the
best gated treatment or breath holding or tracking technique does
not take into account interfractional anatomical changes over the
course of a treatment. It is recognised that heterogeneous varia-
tions in stomach shape and volume occur which may complicate
target localisation and reproducibility during simulation and treat-
ment [7–9]. Intake of food or carbonated drinks can cause gastric
distension with a consequent shift of the CTV extending along
the mucosal wall of the stomach. This shift could potentially influ-
ence dose coverage. In the ideal setting stomach shape and volume
are conserved during radiotherapy, which could be assured by
restricting food and carbonated drinks three hours before treat-
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have problems maintaining their calorie intake and it is not prefer-
able to change their dietary habits. With the implementation of
image-guided radiotherapy (IGRT) and dose recalculation based
on the kilovoltage cone-beam computed tomography (kV CBCT),
we can calculate the delivered dose to the target volume during
treatment and eventually adjust treatment if necessary [10,11].
This study has twomain objectives: (1) to investigate the neces-
sity of adaptive radiotherapy for patients with GEJ tumours in case
of unaccounted stomach changes e.g. gas pockets in the stomach;
(2) to evaluate the impact of food and fluid instructions to assess
verification of geographic miss due to variation in gastric volume.
A quantitative analysis is performed by comparing the dose distri-
butions recalculated on cone-beam CT images (dose-of-the-day) of
the patients’ anatomy during the radiotherapy sessions compared
to the planned dose.
Materials and methods
Patients
This prospectively designed study had the approval of our Inter-
nal Review Board; our clinical protocol was registered at
https://clinicaltrials.gov/ct2/show/NCT02130011. Twenty patients
with pathologically confirmed GEJ tumours were included. They
were treated with (neoadjuvant) CRT between May 2013 and July
2014. All patients had tumour stage cT2–3N1–3. No patient needed
gastrostomy or nasal tube feeding before starting treatment.
We randomly assigned patients to two groups:
(1) Ten patients received food and fluid instructions before
treatment simulation and radiotherapy treatment. They
were asked to fast (ingest no food or carbonated drinks)
for at least three hours before treatment simulation and
radiotherapy planning.
(2) Ten patients received no instructions for gastric emptying or
filling.
CT scanning
Patients were scanned in a supine position and immobilised
using an adjustable cranial and upper arm support (Civco,
Posirest-2, USA) and a kneefix cushion device (Civco, Posirest-2,
USA). All patients underwent a respiratory-correlated 4D CT scan
(Sensation Open, Siemens Erlangen, Germany) using 140 kV and
800 mAs with 3 mm reconstructed slice thickness to incorporate
intrafractional mobility of the target volume. The CT number to
electron density calibration of the 4D-CT scan was undertaken
using a Gammex CT phantom with tissue-equivalent inserts
(Gammex Inc., Wisconsin, USA).Target volume delineation
The gross tumour volume (GTV) was delineated by experienced
radiation oncologists on the mid-expiration phase of the 4D CT
scan, using all available diagnostic information. An expansion of
the GTV by 3 cm is used in the superior and inferior direction to
define the thoracic (CTV_thor) and abdominal (CTV_abd) part of
the CTV, respectively. We applied a 1 cm margin in the radial
dimension, excluding normal tissue. In terms of radiotherapy
fields, our institution irradiated prophylactic nodal areas according
to the primary tumour site [12]. For this study, only the CTV_abd
was of particular interest, compatible with extension of the target
volume along the gastric wall. The abdominal planning target vol-
ume (PTV_abd) was generated by expanding the CTV_abd with a
1 cm margin to account for setup uncertainties. For the thoracic
part of the tumour we applied a 5 mm PTV margin (PTV_thor). Inthis way we limit the volume of lung irradiation and consequently
treatment-related complications.Treatment planning and verification
Radiotherapy consisted of administering a radiation dose of
41.4 Gy or 50.4 Gy in 23 or 28 daily fractions of 1.8 Gy, five times
per week. We used the Eclipse treatment planning system (Varian
Medical Systems, Palo Alto, USA) to generate a RapidArc plan that
ensured PTV coverage by the 95% isodose in accordance with the
International Commission on Radiation Units and Measurements
report 83 and fulfilled the planning constraints for the critical
organs [13,14]. One patient (Appendix A: patient n3) had a
seven-field intensity-modulated radiotherapy plan for which the
Anisotropic Analytical Algorithm (AAA version 10.0.28) in Eclipse
was used to calculate dose. For the other patients, dose was calcu-
lated by the Acuros XB algorithm in Eclipse version 10.0.28 (Varian
Medical Systems, Palo Alto, USA).
All beam deliveries had pretreatment verification with an elec-
tronic portal imaging device which is an important part of our in-
house patient-specific quality assurance programme for these
advanced treatment techniques [15].Workflow of dose-guided radiotherapy
To determine the estimated delivered dose and investigate the
influence of potential gastric and consequent CTV_abd variation
during radiation treatment, we developed the following procedure
(Fig. 1).
Step 1: After positioning the patient on the couch for treatment,
we acquired a kV CBCT image (125 kV, 262 mAs, 13 s acquisition
time) to align the patient as closely as possible to the planned posi-
tion using a match of bony structures. After the automatic image
rigid registration based on mutual information, the radiation ther-
apists could perform an additional manual rigid image registration
to ensure proper alignment of soft tissue in the CTV_abd region.
We performed IGRT on a daily basis throughout the treatment
course for on-line setup correction and for visual detection of
anatomical changes.
Step 2: The GTV was copied to the kV CBCT of fractions 1, 6, 11,
16 and 21 for all patients and after visual inspection there was no
need to adjust the GTV delineation. Furthermore, redelineation of
the CTV_abd was performed on the kV CBCT and a second radiation
oncologist reviewed delineation on these 100 kV CBCTs. The
PTV_abd of the initial planning CT was copied without alteration
to the respective kV CBCT. No other structures were redelineated
because they were of no further relevance for this study. Geo-
graphic miss was defined as expansion of the redelineated
CTV_abd outside the initial planned PTV_abd. This was checked
by visual inspection and calculated as the volume of the CTV_abd
subtracted from the existing planned PTV_abd.
Step 3: Due to the limited field of view (FOV) of the kV CBCT
acquisition, total PTV length systematically oversised the kV CBCT.
We developed a validated automated method for accurately stitch-
ing the three-dimensional CT data to the kV CBCT data, using an
image registration scheme (Appendix B). Preliminary experimental
results demonstrated that ‘‘3D data stitching” provides a good
solution to the voxel mismatch caused by limited FOV length in
the craniocaudal direction [16]. For the treatment of oesophageal
cancer, radiotherapy fields are often large and stitching is a suit-
able solution for features like CTV_abd near a field boundary espe-
cially when part of the beam is out of the field geometry.
Step 4: We performed a registration of the stitched kV CBCT to
the initial planning CT and recalculated the 3D dose distribution
to the patient on the kV CBCT. To achieve higher accuracy in kV
CBCT image-based dose calculation, we used a calibration method
Fig. 1. Workflow ‘how to recalculate dose on kV CBCT’.
Fig. 2. Box-and-Whisker plot shows the distribution of the initial and recalculated
dose in our two cohorts. Dark horizontal lines represent the median, with the box
representing the 25th and 75th percentiles, the whiskers the 5th and 95th
percentiles. Outliers are marked with circles:1.5 * interquartile range (IQR)
<x < 3 * IQR from the box. Asteriks represent extreme outliers defined by
x > 3 * IQR from the box.
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equivalent electron density phantom (model 062, Norfolk, Vir-
ginia). Although high density inhomogeneities still are challenging
for the reconstruction process, there is evidence that clinically
acceptable agreement in key dose–volume parameters between
CT-based and kV CBCT-based planning calculation exists [17].
The same calculation algorithm and preset MU values of the beams
in the initial treatment planning were used.
Step 5: In the final step, we compared the reconstructed dose–
volume histogram (rDVH) parameters from the kV CBCT with the
DVH parameters from the initial planning CT. Potential dosimetric
changes to the CTV_abd are the quantities of interest for comparing
plans in which patients were and were not given food and fluid
instructions. We focused on the following DVH parameters: vol-
ume receiving P95%, P99% and P107% of the prescribed dose
(V95%, V99% and V107%). In addition, we analysed the dose to 5% of
the volume (D5% or near-maximum dose) and the mean, minimum
and maximum dose (Dmean, Dmin and Dmax) for CTV_abd. In this
study, the altered dose distribution was considered a significant
change if [18]:
 V95% of CTV_abd decreased by more than 5% compared to the
initial planning CT
 Dmean of CTV_abd decreased by more than 5% compared to the
initial planning CT
 The percentage of D5% increased by more than 5% compared to
the initial planning CT
Results
The pre-treatment verification revealed no significant dose dif-
ferences for any of the patients, indicating that irradiation was per-
formed as planned. Fig. 2 shows the results of the kV CBCT dose
recalculation for the patient cohort (see Appendix A for more
detailed DVH parameters).
Of the ten patients who did not receive food and fluid instruc-
tions, we detected a geographic miss in four patients (Appendix
A: patient n1, 3, 4 and 5). This notable variation in stomach and
CTV_abd movement and shape was limited to one CBCT per
patient. Coverage of CTV_abd was still excellent in these fractions
with no reduction of more than 5% compared to the initial planning
CT (Fig. 3).
Of the ten patients who received instructions to fast three hours
before simulation and radiotherapy, we observed a geographic
miss in three patients (Appendix A: patient n17, 18 and 20). For
two patients geographic miss was on one CBCT and for one patient
on two CBCTs. In this latter patient, kV CBCT of fraction 6 and 11revealed a gastric gas pocket localised in the CTV_abd. This gas
pocket was not present on the initial planning CT (Fig 4). This is
the only patient in whom we observed more than 5% reduction
in dose coverage but this was not in the region of the CTV_abd part
that was outside the PTV_abd. Looking in more detail, we realised
that the underdosage was situated in an in-air- PTV_abd region
caused by the gas pocket. This observation did not lead to adaptive
treatment planning in this patient.
Comparing the CBCT plan to the treatment plan there was no
significant difference between the two groups for V95%, Dmean and
D5%. In one fraction (Appendix A: patient n5) we observed an
increase of D5% with 6% but this was not considered alarming. For
both treatment groups, there was no decline of Dmean of more than
5% and no increase of D5% with more than 5%. In general, we
observed a trend towards a higher Dmax and V107% in all CBCTs
(Appendix A: patients n3 and 15) or a limited number of CBCTs
(Appendix A: patient n2 and 20) compared to the planning CT.
When we looked at the D5% instead of the V107% the dose–volume
differences were considerably smaller. After matching the PTV_abd
on the slow kV-CBCT to the initial planning mid-expiration CT, we
Fig. 3. Visual inspection of CTV_abd outside PTV_abd with good coverage (red arrow). Light green = GTV; orange = CTV_abd; red = PTV_abd; dark blue = stomach;
yellow = 95% isodose line; cyanic blue = 50% isodose line. (A) Dose distribution after recalculation on kV CBCT CT; (B) magnified view of 95% isodose line still covering the part
of CTV_abd located outside the PTV_abd. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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absorption as it passed through more air. Details about the image
characteristics are given in Appendix C. Using highly conformal
irradiation techniques, a steep dose fall-off in treatment planning
for oesophageal cancer was created; so the smallest shift of the
dose distribution (e.g. because of an aberrant breathing pattern)
may result in a large shift of dose–volume metrics. Although this
was not the scope of our study, these additional findings show
the dependency on respiratory motion in CBCT dose recalculation.
This could be solved by using the first day of CBCT data sets rather
than planning CT to provide reliable dosimetric parameters com-
parison. As a result of evaluating the dose–volume histogram data
listed in Fig. 2, there seemed to be no need for adaptive radiother-
apy planning based on both quantitative dose analysis and visual
interpretation of the kV CBCT.Discussion
Nowadays, IGRT is widely used for correctly positioning
patients, but in this study we focused on the kV CBCT imaged gas-
tric anatomic changes of patients with GEJ tumours. We investi-
gated CBCT for dose calculation to predict and assess the dose
delivered to the patient and use it for adaptive radiotherapy. We
monitored a total 100 kV CBCTs from 20 patients who either were
or were not instructed to restricted intake of food or carbonated
drinks three hours before simulation and treatment. Only one
patient did not achieve the pre-determined rDVH criteria with
reduced dose coverage. However, this reduced dose coverage was
in air and was not clinically relevant to the treatment protocol.Although this was only a weekly dose recalculation instead of a
daily analysis, we expect no large shift of the integral and cumula-
tive dose distribution relative to the CTV_abd since we found no
systematic errors. Even with a strict gastric filling scenario, physi-
ological organ motion and shape variation seems unpredictable
and unavoidable. Our study affirms that giving no instructions is
the correct approach for patients with GEJ tumours who already
often have difficulties maintaining their dietary habits during
CRT. Still when thinking of reducing PTV margin to less than
1 cm, paying attention to image-guided based patient setup error
and instructing radiation therapists to observe potential geometric
misses are strategies that can be utilised to reduce compromised
coverage of the CTV. Future research should extend this study with
more participants to further confirm these results.
A study by Bouchard et al. [19] also focused on GEJ tumours and
found that the filling status of the stomach had no impact on the
actual dose to the GTV. However when there is an increase in gas-
tric volume, they warn against neglecting the inadequate doses to
the PTV, which could result in small geographic misses. Bouchard
et al. [19] did not analyse the potential dosimetric errors induced
by gas pockets or different filling state of the stomach during radio-
therapy treatment.
The advantage of our study is that it brings the focus back to the
main objective of radiotherapy: namely ensuring that the pre-
scribed dose is delivered to the correct location. Organs like the
stomach may inflate and deflate over time and we focused on
the part of the target volume which is most prone to variability:
the part of the CTV extending into the stomach. Since a dose deficit
to a 1% volume of the target that is larger than 20% of the prescrip-
tion dose still may lead to serious loss of tumour control probabil-
Fig. 4. Light green = GTV; orange = CTV_abd; red = PTV; dark blue = stomach; yellow = 95% isodose line; magenta = 107% isodose line and cyanic blue = 50% isodose line. (A)
Initial plannings mid-expiration CT; (B) redelineation on kV CBCT with the presence of a gas pocket in the stomach; C: dose recalculation on the kV CBCT shows that the 95%
isodose line shifted inside the in-air-PTV region (red arrow). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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the target [20]. In our study the biological impact of small CTV_abd
expansion outside the PTV_abd was considered to be limited. Mod-
est cold spots as observed in our study will likely not reduce
tumour control probability unduly [21,22]. Our study information
may also prove useful if any questions arise about patient guideli-
nes for food and fluid during treatment for GEJ cancer.
The major drawback of our study is the offline approach, includ-
ing the fact that the radiotherapy fraction had already been deliv-
ered before a possible insufficient dose coverage was detected. We
did not investigate the influence of dose–volume parameter differ-
ences in organs at risk. We do not expect a violation of dose con-
straints to the gastric fundus regarding the potential influence of
postoperative anatomic leakage [23]. We recognise that patients’
dietary compliance was only tracked on a weekly basis. Another
limitation is the limited reconstruction length of the kV CBCT
(i.e. 17 cm) where the PTV length systematically exceeded these
features. Further developments in merging sectional CBCTs into
an accurate, larger single image would overcome the limitation
of the small FOV of CBCT [24]. The mid-expiration phase of treat-
ment planning is only a snapshot in time, while kV CBCT acts as
a slow CT in which breathing and peristaltic motion create rather
blurry images. The current study has shown that the relative
motion and position of the tumour at the time of treatment may
not match that of the planning 4DCT scan. Patients can present
with different respiratory patterns during radiotherapy treatment
[25]. Respiratory-correlated cone beam could improve imaging
quality and correct recalculation. Visual qualitative inspection
of CBCT scans and redelineation of target volumes is time-consuming and prone to inter-observer variation in human inter-
pretation. The image quality was clinically sufficient to delineate
the stomach, but the uncertainty for the manual delineation of
other structures and OARs is high due to the poor image quality
and artifacts caused by gas-pockets and therefore merely enough
for the purpose of adaptive radiotherapy [26]. The kV CBCT image
quality continues to improve: recent results indicate a 1–2% soft-
tissue contrast resolution [27,28]. Dose recalculation on kV CBCT
should be done with clear awareness of its limitations and a reli-
able calibration between the pixel values (reconstructed grey-
scale values) within the reconstructed image and the electron den-
sity of the material being imaged is mandatory, especially in the
presence of air gaps and metal artifacts [29]. These inconsistencies
and artifacts are inherent to the use of kV CBCT, which might be
solved by technological advances.
Ideally, we would perform on-line adaptive radiotherapy in
order to monitor and modify dose before treatment delivery ‘on-
line’. Until now, the many steps involved before one can display
the estimated delivered dose distribution on a near real-time
image like kV CBCT, have made it difficult to implement this in
daily clinical practice. There are application tools to automate
some of these steps (e.g. auto-propagation of contours) and facili-
tate the workflow process, but these are not yet sufficiently well
integrated into current commercial platforms to use on a daily
scale.
In addition to a better matching of the patient’s position, IGRT
with kV CBCT images offers a more powerful use to reconstruct
the estimated delivered dose. To our knowledge, this is the first
study to investigate variations in gastric dimension and their effect
L. Van De Voorde et al. / Radiotherapy and Oncology 117 (2015) 442–447 447on the (near) real-time given dose. Our study summarises the work
needed to implement dose-guided radiotherapy with kV CBCT for
patients with GEJ tumours and comments on the remaining chal-
lenges. We conclude that when an adequate PTV margin of 1 cm
is applied, dietary instructions do not contribute to optimal target
coverage. CBCT before treatment does provide information on
interfractional and interindividual variations in stomach volume
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